Market Share of Multiple Myeloma Industry
The multiple myeloma market is fragmented and competitive with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Karyopharm Therapeutic Inc., Sanofi S.A., Amgen Inc., Takeda Pharmaceutical Company, and Bristol-Myers Squibb Company, among other players.
Multiple Myeloma Market Leaders
Bristol-Myers Squibb Company
Takeda Pharmaceutical Company Limited
Amgen Inc.
Sanofi S.A.
Karyopharm Therapeutics Inc.
*Disclaimer: Major Players sorted in no particular order
